This inventor holds 1 USPTO granted patent. Top assignee: Medimmune Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Inventor Melanie Boyle
Introduction
Melanie Boyle is a notable inventor based in Cambridge, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of targeted binding agents.
Latest Patents
Melanie Boyle holds a patent for "Targeted Binding Agents Against B7-H1." This innovative work addresses critical challenges in immunotherapy and has the potential to impact cancer treatment significantly. He has 1 patent to his name.
Career Highlights
Melanie Boyle is currently employed at MedImmune Limited, a leading biotechnology company. His work at MedImmune focuses on advancing therapeutic solutions that can improve patient outcomes.
Collaborations
He collaborates with talented professionals such as Christophe Queva and Michelle Morrow, contributing to a dynamic research environment that fosters innovation.
Conclusion
Melanie Boyle's work exemplifies the spirit of innovation in biotechnology. His contributions are paving the way for advancements in targeted therapies, showcasing the importance of dedicated inventors in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile